Financials JMI Syringes & Medical Devices Limited

Equities

JMISMDL

BD0000JBCL09

Medical Equipment, Supplies & Distribution

End-of-day quote Dhaka S.E. 06:00:00 2024-05-29 pm EDT 5-day change 1st Jan Change
142.3 BDT +3.57% Intraday chart for JMI Syringes & Medical Devices Limited +0.99% -44.31%

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 2,582 5,150 6,398 7,317 6,902 7,679
Enterprise Value (EV) 1 4,369 4,933 6,522 7,339 7,028 7,760
P/E ratio 34.2 x 156 x 66.6 x 82.1 x 68.6 x -51.2 x
Yield 1.28% 0.64% 1.04% 0.91% 1.57% 0.39%
Capitalization / Revenue 1.82 x 2.9 x 3.24 x 3.67 x 2.83 x 4.38 x
EV / Revenue 3.07 x 2.77 x 3.3 x 3.68 x 2.88 x 4.42 x
EV / EBITDA 14 x 12.9 x 24 x 28.6 x 24.6 x 53.3 x
EV / FCF -17.3 x 18.4 x -28.9 x 38 x -704 x 33.7 x
FCF Yield -5.79% 5.45% -3.46% 2.63% -0.14% 2.97%
Price to Book 3.29 x 2 x 2.38 x 2.7 x 2.51 x 2.96 x
Nbr of stocks (in thousands) 14,960 14,960 30,056 30,056 30,056 30,056
Reference price 2 172.6 344.3 212.9 243.5 229.6 255.5
Announcement Date 12/6/18 11/6/19 11/5/20 11/7/21 12/3/22 11/7/23
1BDT in Million2BDT
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 1,421 1,778 1,977 1,994 2,438 1,755
EBITDA 1 311.8 382.2 271.5 256.7 285.6 145.5
EBIT 1 256.3 327.2 206.9 185.5 212.3 71.24
Operating Margin 18.03% 18.4% 10.47% 9.3% 8.71% 4.06%
Earnings before Tax (EBT) 1 104.3 149.6 215.9 186.2 207.7 64.46
Net income 1 75.5 66.55 96.04 89.11 100.6 -150
Net margin 5.31% 3.74% 4.86% 4.47% 4.13% -8.54%
EPS 2 5.047 2.213 3.195 2.965 3.347 -4.989
Free Cash Flow 1 -252.8 268.8 -225.8 193 -9.981 230.2
FCF margin -17.79% 15.11% -11.43% 9.68% -0.41% 13.11%
FCF Conversion (EBITDA) - 70.32% - 75.17% - 158.17%
FCF Conversion (Net income) - 403.81% - 216.56% - -
Dividend per Share 2 2.206 2.206 2.206 2.206 3.600 1.000
Announcement Date 12/6/18 11/6/19 11/5/20 11/7/21 12/3/22 11/7/23
1BDT in Million2BDT
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 1,787 - 124 21.2 127 81.1
Net Cash position 1 - 217 - - - -
Leverage (Debt/EBITDA) 5.731 x - 0.457 x 0.0826 x 0.4434 x 0.5576 x
Free Cash Flow 1 -253 269 -226 193 -9.98 230
ROE (net income / shareholders' equity) 9.88% 3.96% 3.65% 3.3% 3.69% -5.61%
ROA (Net income/ Total Assets) 6.09% 7.01% 4.07% 3.6% 4.06% 1.39%
Assets 1 1,240 949.8 2,362 2,476 2,477 -10,809
Book Value Per Share 2 52.40 172.0 89.50 90.20 91.40 86.40
Cash Flow per Share 2 0.7000 22.60 0.9500 1.520 3.050 1.720
Capex 1 75.9 45 247 60.3 97.9 44.4
Capex / Sales 5.34% 2.53% 12.51% 3.02% 4.01% 2.53%
Announcement Date 12/6/18 11/6/19 11/5/20 11/7/21 12/3/22 11/7/23
1BDT in Million2BDT
Estimates
  1. Stock Market
  2. Equities
  3. JMISMDL Stock
  4. Financials JMI Syringes & Medical Devices Limited